Phase 1 Respiratory Viral Infection Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Safety and Pharmacokinetics of Ingavirin Forte, Capsules, 90 mg + 20 mg (Valenta Pharm JSC, Russia) Compared With Ingavirin, Capsules, 90 mg, Under Fasting and Fed Conditions.

InfluenzaAcute Respiratory Viral Infections

Valenta Pharm JSC36 enrolled1 locationNCT07645534

Recruiting

Phase 1

Macrophage Regulation of Ozone-Induced Lung Inflammation

Respiratory Viral Infection

Robert Tighe, MD100 enrolled1 locationNCT05773001